Purpose: This hospital-based study has determined the change over time (1972-1974 and 1979-1994) Down syndrome was not diagnosed in any affected infants prenatally. In the early 1980% amniocentesis was the primary method of diagnosis; later, maternal serum screening and ultrasonography were as likely to be the first method of detection. Most couples (86%) elected to terminate pregnancies with affected fetuses.
INTRODUCTION
It has long been recognized that the risk of having an infant with Down syndrome increases with th; age of the mother during pregnancy. When the diagnostic technique of amniocentesis became availabl; widely in th;late 1970s and early 1980s, it was recommended that the test be offered to older pregnant women. Age 35 years and older was established, by analyses of cost and benefit, as the maternal age at which amniocentesis should be offered routinely as an option.',* During the past 15 years, two additional prenatal screening tests have been offered to pregnant women younger than 35 years: 1) the routine use of maternal serum screening for high and low levels of alphafetoprotein (AFP), and later other analytes including human chorionic gonadotropin (hCG) and estriol, at 16 weeks of gestation,' and 2) ultrasonography at 16 to 18 weeks? leading to the identification of structural abnormalities of the fetus. The discovery of a low level of maternal AFP or structural anomalies such as a thickened nuchal skin fold, by sonography, would prompt the offer of amniocentesis. When all of these types of prenatal screening, i.e. amniocentesis, maternal serum screening, and ultrasonography, identified a fetus with an abnormality such as Down syndrome before 24 menstrual weeks of pregnancy, the parents had the option of elective termination of the pregnancy.
In assessing the impact of prenatal diagnosis on pregnancies of fetuses with Down syndrome, it should be noted that all affected fetuses would not be expected to survive long enough to become a fullterm pregnancy? For example, Hook et al. 5 reported that spontaneous fetal death occurred in 25.6% of fetuses with Down syndrome that had been detected by amniocentesis in the second trimester.
We describe a decrease in the portion of infants with Down syndrome who were liveborn at a large university hospital (Brigham and Women's Hospital [BWH] in Boston, MA) beginning before prenatal diagnosis was routine (1972) (1973) (1974) and continuing from 1979 through 1994. Although this is not an unselected population of pregnant women with uniform management, this report has the advantage of including liveborn and stillborn births, as well as pregnancies with affected fetuses that were terminated electively.
METHODS AND MATERIALS
AU infants and fetuses with Down syndrome were identified by an active malformations surveillance program described pre~iously,~ which was conducted Monday to Friday until the late 1980s when coverage on Saturday or Sunday was added. This survey begins with a review of the findings in the pediatricians' initial and discharge examinations of each infant born at this hospital. In addition, the medical records of all infants transferred to the adjacent Boston Children's Hospital, autopsy reports, prenatal ultrasound reports filed in the Newborn Intensive Care Unit, and reports from the hospital's Cytogenetics Laboratory were reviewed to identify all infants with any type of chromosome abnormality. For this study, the results of chromosome analysis were sought for each infant; if none was available, the diagnosis was based on the findings recorded in the physical examination records.
Demographic information, including the age of each parent, racidethnic group, insurance status, family history of birth defects, and the results of all prenatal testing, was obtained whenever possible in a postpartum i n t e~e w .
During the intewiew, the mother was asked to sign an Informed Consent Document. The process of obtaining consent was in Genetics,. Mediche accordance with the ethical standards for human experimentation established by the Declaration of Helsinki in 1975 Helsinki in , revised in 1983 . If the mother was not interviewed by the research assistant, her medical record was reviewed.
The periods surveyed were February 16,1972 to February 14, 1975 (referred to hereafter as 1972 -1974 and January 1,1979 through December 31,1994 . (The hiatus of 4 years occurred because of a lack of space and funds to support the surveillance program.) During the study there were 159,928 livebirths, 1,303 stillbirths (>20 weeks gestation), and 2,600 elective terminations (during the second trimester of pregnancy). From this total of 163,831 we subtracted all infants with other types of major malformations (n = 1805), such as renal agenesis and diaphragm defects, whose mothers had been transferred to BWH, because of the identification of a fetal abnormality at another hospital, to define the total population of 162,026 livebirths, still births, and elective terminations in the second trimester.
We assigned the mothers of affected infants to two groups, maternal nontransfers and maternal transfers. The nontransfer group induded women who had always planned to deliver at this hospital. The analysis we report was carried out only on the infants of nontransfers. The transfer group included women who had planned to deliver at another hospital, but transferred their care to this hospital after a diagnosis of a fetal abnormality. From 1972 through 1974 our interviews showed that none of the mothers of infants with Down syndrome had been transferred to the hospital for delivery after the mother had prenatal screening by either sonography or amniocentesis. (Amniocentesis was used to diagnose chromosome abnormalities in three fetuses from 1972 to 1974: trisomy 18 [2 infants] and 4 7 m [ 1 infant] ). However, this dassification by transfer status was necessary in 1979 when the surveillance program resumed. The transfer status of each woman from 1979 to 1990 was assigned initially by the research assistant who had ascertained information about each infant and had either interviewed the mother or reviewed her medical record for that admission but not previous admissions. The questions asked about the mother's transfer status became more explicit when the questionnaire was revised in 1990.
Because of the importance of transfer status for this study, we reevaluated the transfer status of all affected infants identified in the years 1979 through 1990. This evaluation was done in two ways: 1) a questionnaire was sent to 2 18 women who had had affected infants through 1990; and 2) a review was conducted of the medical records of all mothers of affected infants who did not return the questionnaire. The short questionnaire asked about the woman's transfer status and the method of prenatal screening used. The entire medical record was reviewed for comments about where the mother had planned to deliver, whether she had had appointments at BWH during this pregnancy before any prenatal screening, and whether her last child had been born at BWH.
The infants identified prenatally were also subdivided into those identified before or after 24 weeks of gestation, because elective termination is not legal in the state of Massachusetts after the 24th menstrual week.
Demographics
Information was obtained about the portion of all postpartum women at BWH who were 35 years of age and older from other research studies8*' and hospital reports."
RESULTS

Transfer status
Of the 218 short questionnaires mailed, 46 were returned undelivered, 78 (45%) women responded, and 94 did not. Eleven (14%) of the respondents changed their transfer status: three (4%) from transferred to nontransferred, and eight (10%) from nontransferred to transferred.
Based on the research assistant's review of the 140 other medical records, the transfer status of 19 (14%) women was changed: eight (5%) moved to nontransfer, and 11 (9%) moved to maternal transfer.
Cytogenetics
Based on the results of the assessment of transfer status there were 265 nontransfer, nonmosaic affected infants and fetuses in terminated pregnancies. The results of chromosome analysis were available for 262 infants: 257 (98%) had nondisjunction trisomy 21, and five (2%) had translocation trisomy 21. The other three affected nontransfer infants were either diagnosed clinically or had cytogenetic studies performed elsewhere; the printed reports from these cases could not be obtained. Excluded from Table 1) . The increase over time was significant (P = 0.001), using a Poisson test for trend analysis. When restricted to the prevalence rate of livebom infants with Down syndrome, exduding stillbirths and elective terminations, the decrease over time was not significant (P = 0.069).
Included in the evaluation of this change in prevalence rate over time was a determination of the portion of all mothers of affected infants ( 
Birth status
Among affected infants of nontransferred mothers 35 years and older, all five born in the 3-year period before the advent of prenatal diagnosis (1972) (1973) (1974) were liveborn ( Table 2 and Fig. 1 (Fig. 2) . The portion of those diagnosed prenatally rose from 10% in 1982 to 1984 to 67% in 1991 to 1992 and was 58% in 1993 to 1994 ( Table  3) . When the prenatal diagnosis of Down syndrome was determined before 24 weeks of gestation, the parents of 27 (87%) of the 31 affected fetuses chose to terminate the pregnancy. Like the women 35 years and older, very few (2.4%; 3 of 127) affected infants were stillborn in the population of women younger than 35 years.
Method of prenatal detection
Among women 35 years and older, the first abnormal prenatal test result was almost always obtained through amniocentesis in the period from 1979 through 1987 (Table 3) . Thereafter, the portion detected initially by ultrasound increased, primarily because physical abnormalities were identified during the sonography examination before a scheduled The technology that makes the prenatal diagnosis of fetal abnormalities possible has evolved steaddy during the time covered in this analysis . For example, amniocentesis was expanded to include "early" amniocentesis at 12 to 15 weeks of gestation.1° In some centers, although not this one, chononic villus sampling at 9 to 11 weeks of gestation became a popular alternative to amniocentesis. W~th regard to maternal serum AFP screening, it was reported in 1984 that low levels of AFP could be a marker of Down syndrome and trisomy 18." Estriol and hCGIZ were added as additional markers that increased the detection of fetuses with Down syndrome from 20% by AFP testing alone13 to 65% by testing which measured AFP, hCG, and estriol.14 The technical sophistication of ultrasonography and the skill of the sonographer improved during these years.
Other medical centers may also have had their own areas of clinical research and participation in new innovations. For example, this hospital carried out very few chorionic villus sampling procedures, but was actively involved in the development of "early" amniocentesis as an option.1° This hospital's obstetrics clinic, which provides medical care to about 2500 pregnant women each year, instituted rnaternal serum AFP screening as a routine option in mid-1985 and began the maternal serum triple marker screening (AFP, hCG, and estriol) in 1990. The medical care of many other pregnant women was provided by private obstetricians who instituted these screening programs at different times and used laboratories outside of the hospital. Prenatal ultrasonography has been an area of clinical research both in the ho~pital'~ and at a large nearby private sonography office,'' an interest that has led to an increase both in skill level and awareness of sonographers. Therefore, this hospital was a setting in which the prenatal screening offered to each pregnant woman changed during the study years 1972 to 1994.
A similar high frequency of elective termination of affected fetuses with a prenatal diagnosis (92%) was observed in the southeastern United States through 198616 and in England between 1989 and 1993. 17 The same steady increase in the frequency of both prenatal detection and elective termination of the pregnancies with affected fetuses has been observed for other fetal abnormalities, such as anencephaly,18 spina bifida,lg and heart defects:O at this and other medical centers. These similar patterns reflect the impact of the same technologies on the prenatal detection of abnormalities in the fetus before 24 weeks of gestation.
This study showed that the prevalence of Down syndrome was significantly higher in 1991 to 1994 than it was in 1972 to 1974. We suggest several possible explanations for this increase. First, the increase in the prevalence rate may reflect an increase in the proportion of pregnant women 35 years and older, the high-risk group among all new mothers. Hook et al.5 and Snijders et al.6 reported the rate of fetal death among affected fetuses in whom Down syndrome was diagnosed by amniocentesis. The rate was 25.6% in the first study5; in the second study: it was estimated for women 35 years and older that the frequency of trisomy 21 at birth was 54% lower than at 9 to 14 weeks of gestation and 33% lower than at 15 to 20 weeks of gestation. This is also suggested by the fact that only 1.3% (3 of 263) of the affected infants of nontransferred mothers were stillborn, which is lower than the proportion (5-10%) estimated for chromosome abnormalitie~.~~ Third, there may have been errors in the designation of the transfer status of the mothers of affected infants. However, we were reassured that the rate of potential misclassification is very low based on the findings in the questionnaires returned by 78 women, the findings in the detailed review of the medical records, and the high degree of correlation between the interpretation from the review and the women's responses to the study questionnaire about transfer status.
The potential biases inherent in a university hospital should be noted. Theoretically, women could have begun obstetrical care at this hospital, had prenatal diagnosis studies at another facility, terminated the pregnancy elsewhere, and never have been identified in a study like this one. This decrease will have a significant impact on the medical services used by infants with Down syndrome. However, this change in the management of pregnancies of fetuses with Down syndrome will not be detected by those public health programs, e.g. through birth certificates, which do not identify those pregnancies terminated electively because of fetal abnormalities.
CONCLUSIONS
Between 1972 and 1994 the percentage of infants with Down syndrome who were liveborn decreased dramatically. There was no prenatal detection between 1972 and 1974. In the early 1980s, this decrease reflected the impact of amniocentesis among women 35 years and older. By the late 1980s prenatal detection was common among women younger than 35 years and detection was by several modalities including AFP screening, sonography, and amniocentesis. When the diagnosis was established before 24 weeks of gestation, 86% to 87% of the parents chose elective termination of the pregnancy. This project was supported at different times by grants from the Massachusetts Developmental Disabilities Fund, Merrill Dow Pharmaceuticals, the Easter Seals Research Program, the New England Regional Genetics Group, and the Peabody Foundation. We thank Louise Ryan, PhD for help with statistical analyses. This study benefited significantly from the diligence of many research assistants and the hospital staff in cytogenetics, pediatrics, pathology, and obstetrics.
